Compassion-focused therapy for reducing self-stigma in mental health disorders
Official title: Compassion Focused Therapy (CFT) for the Reduction of the Internalized Stigma of Mental Disorders: a Multi-center, Prospective, Randomized, Controlled Study
Run by University Hospital, Strasbourg, France · NCT05698589 · Data updated 2026-11-12
This study is testing whether Compassion Focused Therapy can help people with mental health disorders feel better about themselves and reduce feelings of shame.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 336 (estimated) |
| Sponsor | University Hospital, Strasbourg, France Academic / other |
| Locations | 7 sites (Bordeaux and 6 other locations) |
| Status | Recruiting |
| Started | April 3, 2023 |
| Main results expected | March 1, 2028 |
| Study ends | March 1, 2028 |
| Registry record updated | August 19, 2026 |
| Trial ID | NCT05698589 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with chronic psychiatric or neurodevelopmental disorders experiencing moderate to high levels of self-stigma.
✕Probably not a fit
Patients currently in an acute episode of their disorder or those participating in other interventional studies may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to address self-stigma among individuals with chronic psychiatric disorders such as bipolar disorder, schizophrenia, depression, borderline personality disorder, and autism spectrum disorder. It employs Compassion Focused Therapy (CFT), a cognitive behavioral approach designed to reduce shame and improve self-compassion, which are critical for enhancing coping skills and treatment adherence. Participants will be assessed for their level of self-stigma and severity of their condition to determine eligibility. The intervention seeks to foster a more positive self-relationship and facilitate better integration into society.
Why it matters
Potential benefit: If successful, this approach could significantly improve the mental health and social integration of patients by reducing self-stigma and enhancing treatment adherence.
How similar studies have gone: While the specific application of Compassion Focused Therapy for self-stigma in these disorders is novel, similar therapeutic approaches have shown promise in improving mental health outcomes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patient ≥18 years of age 2. Patient informed of the results of the preliminary medical examination 3. Patient affiliated to a social health insurance plan (beneficiary or beneficiary's family) 4. Patient with one or several diagnoses of chronic psychiatric disorder (schizophrenia, schizoaffective disorder, bipolar disorder, recurrent major depression, borderline personality disorder) or a neurodevelopmental disorder (autism spectrum disorder) treated as an outpatient or in a day hospital 5. CGI-Severity score\<6 assessed by the psychiatrist (Berk et al., 2008) ISMI score indicating moderate to high self-stigma (\>2.5; Lysaker et al., 2007) Exclusion criteria: 6. Patient in an exclusion period determined by a previous or ongoing study 7. Patient participating in an interventional study involving psychotherapy or an experimental drug 8. Patient in acute episode of their disorder according to the CGI Severity score 9. Patient in a medical emergency or immediate life-threatening situation 10. Patients with an intellectual disability (IQ\<70) estimated via the fNART (Mackinnon \& Mulligan, 2005) 12\. Legal issues: care under constraint or patient deprived of freedom because of a judicial measure 13. Patient who does not speak and read French sufficiently
Where it's running
-
Service de Psychiatrie, Hôpital Civil, Hôpitaux Universitaires de Strasbourg
Strasbourg, France Recruiting -
Pôle de Psychiatrie Adulte, Hôpital Charles Perrens
Bordeaux, France Not yet recruiting -
Ch Le Vinatier
Bron, France Not yet recruiting -
CHU de Clermont-Ferrand, Hôpital Gabriel Montpied, Service de Psychiatrie B
Clermont-Ferrand, France Not yet recruiting -
Pôle Hospitalo-Universitaire de Psychiatrie d'adultes et d'addictologie du Grand Nancy, Centre Psychothérapique de Nancy
Laxou, France Not yet recruiting -
CHU de Montpellier, Psychiatrie d'adultes, Hôpital la Colombière
Montpellier, France Not yet recruiting
Show 1 more location
-
Etablissement Public de Santé Mentale (EPSM) de la Marne, Site Pierre-Briquet, Unité de réhabilitation psychosociale
Reims, France Not yet recruiting
Study contacts
- Study coordinator: Luisa Weiner
- Email: weiner@unistra.fr
- Phone: 0033388116312
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cerebellar stimulation to improve cognitive function and mood
This study is testing if a special brain stimulation can help improve thinking and mood in people with schizophrenia, autism, bipolar disorder, and Parkinson's disease.
-
Assessing the safety of lumateperone in young patients with schizophrenia or bipolar disorder
This study is testing if lumateperone is safe for young people with schizophrenia or bipolar disorder who will take the medication daily for 26 weeks.
-
Using brain stimulation to improve thinking skills in people with mental health conditions
This study is testing if a brain stimulation treatment can help improve thinking skills in people with mental health conditions like depression, bipolar disorder, and ADHD.
-
Culturally tailored nurse-led COPE program for caregivers of children with autism
This study tests a culturally adapted COPE program led by nurses to help primary caregivers of children with autism feel less distressed, alongside standard care.
-
Effects of comorbidity on people with severe mental illness
This study tests how having both alcohol/substance use and a severe mental illness affects hospitalizations, medications, and social participation among adults followed at a mental health center.
-
Venous Tourniquet with Low-Dose Sugammadex vs Arterial Tourniquet for Seizure Monitoring During ECT
40 patients undergoing ECT will have a venous tourniquet on one arm and an arterial tourniquet on the other to see which method better reveals motor seizures.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.